Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cumberland Pharmaceuticals Inc. (CPIX) vs Organigram Global Inc. (OGI)

Cumberland Pharmaceuticals Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. is the larger, with a market value of $155.1M against $120.0M — 1.3× the size. Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.4×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against 32.0%. Organigram Global Inc. has the higher net margin (28.4% vs −26.2%) and the higher return on invested capital (−1.53% vs −34.2%). Across the 18 metrics below, Organigram Global Inc. leads on 14 and Cumberland Pharmaceuticals Inc. on 4.

Valuation

Metric CPIX OGI Drug Manufacturers Specialty & Generic median
P/E n/m 2.37 20.14
P/S 2.73 0.67 2.25
P/B 6.66 0.42 1.90
Price to free cash flow 197.97 n/m 16.54
EV/EBITDA n/m 16.79 12.29
EV/Sales 2.89 0.70 2.56
Earnings yield (9.33%) 42.26% (2.99%)
Free cash flow yield 0.51% (14.22%) 0.00%

Profitability

Metric CPIX OGI Drug Manufacturers Specialty & Generic median
Gross margin 82.80% 36.47% 53.94%
Operating margin (17.39%) (3.91%) 0.00%
Net margin (26.17%) 28.44% 0.00%
Free cash flow margin 1.38% (9.46%) 0.00%
Return on equity (48.76%) 20.20% (0.40%)
Return on assets (16.70%) 12.70% (3.32%)
Return on invested capital (34.23%) (1.53%) 0.00%

Growth

Metric CPIX OGI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 31.98% 39.51% 10.01%
EPS growth (last fiscal year) 58.70% 60.00% —
Revenue growth, 5-year CAGR 3.52% 24.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPIX OGI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.04 0.05
Current ratio 0.96 2.61 2.31
Net debt to EBITDA (4.58) (31.56) 0.85

Dividend

Metric CPIX OGI Drug Manufacturers Specialty & Generic median
Dividend yield 2.07% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CPIX OGI Drug Manufacturers Specialty & Generic median
Market cap 120.01m 155.11m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack